Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Hydroxychloroquine for Potential Covid-19 Treatment

Drug Name

Hydroxychloroquine

Developer

Sanofi

Therapy Class

Antimalarial

Product Description

4-aminoquinoline

Current Indication

Malaria, discoid and systemic lupus erythematosus, and rheumatoid arthritis

Market Class

Infectious disease

Development Status

Approved in the US and Europe for the above-mentioned indications
Expand
Close
Close
Close

Go Top